INTRACORONARY ACETYLCHOLINE-INDUCED PROLONGATION OF THE QT INTERVAL AND TORSADE-DE-POINTES IN LONG QT INTERVAL SYNDROME

被引:0
|
作者
AIZAWA, Y
MATSUBARA, T
HIGUCHI, K
WASHIZUKA, T
TAMURA, Y
UCHIYAMA, H
IGARASHI, Y
SHIBATA, A
机构
来源
JAPANESE HEART JOURNAL | 1994年 / 35卷 / 05期
关键词
LONG QT INTERVAL SYNDROME; QT PROLONGATION; ACETYLCHOLINE; TORSADE-DE-POINTES;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 75-year-old female had syncopal episodes from Torsade des Pointes (TdP). Her electrocardiogram showed a prolonged QT interval which was not associated with electrolyte imbalances or drug therapy. Similar electrocardiographic abnormalities were found in three family members. Electrophysiologic study showed a mildly prolonged effective refractory period of 260-290 msec, but no tachyarrhythmia was induced. Coronary arteriography was normal but intracoronary acetylcholine unexpectedly induced a prolongation of the QT interval and TdP. Direct action of acetylcholine on the ventricular muscle was suggested.
引用
收藏
页码:683 / 688
页数:6
相关论文
共 50 条
  • [41] AMIODARONE THERAPY IN A PATIENT WITH SOTALOL INDUCED TORSADE-DE-POINTES - VALUE OF DETERMINATION OF QT DISPERSION
    VANDELOO, A
    KLINGENHEBEN, T
    HOHNLOSER, SH
    ZEITSCHRIFT FUR KARDIOLOGIE, 1994, 83 (12): : 887 - 890
  • [42] Fluconazole-associated QT interval prolongation and Torsades de Pointes in a paediatric patient
    Yuksekgonul, Ayse Unal
    Ertugrul, Ilker
    Karagoz, Tevfik
    CARDIOLOGY IN THE YOUNG, 2021, 31 (12) : 2035 - 2037
  • [43] Epidemiology of symptomatic drug-induced long QT syndrome and torsade de pointes in Germany
    Sarganas, Giselle
    Garbe, Edeltraut
    Klimpel, Andreas
    Hering, Rolf C.
    Bronder, Elisabeth
    Haverkamp, Wilhelm
    EUROPACE, 2014, 16 (01): : 101 - 108
  • [44] Novel therapeutics for treatment of long-QT syndrome and torsade de pointes
    Khan, IA
    Gowda, RM
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2004, 95 (01) : 1 - 6
  • [45] Drug-induced long QT and torsade de pointes: recent advances
    Kannankeril, Prince J.
    Roden, Dan M.
    CURRENT OPINION IN CARDIOLOGY, 2007, 22 (01) : 39 - 43
  • [46] Clinical prediction rule for torsade de pointes in patients with druginduced QT prolongation
    Othong, Rittirak
    Prasertsup, Warisa
    Kazzi, Ziad
    CLINICAL TOXICOLOGY, 2018, 56 (10) : 931 - 933
  • [47] DRUG-INDUCED QT INTERVAL PROLONGATION
    Zhamba, A. O.
    WORLD OF MEDICINE AND BIOLOGY, 2015, 51 (03): : 125 - 129
  • [48] Osimertinib-induced cardiac failure with QT prolongation and torsade de pointes in a patient with advanced pulmonary adenocarcinoma
    Ikebe, Saori
    Amiya, Ryohei
    Minami, Seigo
    Ihara, Shoichi
    Higuchi, Yoshiharu
    Komuta, Kiyoshi
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2021, 10 (01) : 68 - 71
  • [49] Drug-induced QT-interval prolongation and recurrent torsade de pointes in a child with heterotaxy syndrome and KCNE1 D85N polymorphism
    Lin, Lisheng
    Horigome, Hitoshi
    Nishigami, Naoko
    Ohno, Seiko
    Hone, Minoru
    Sumazaki, Ryo
    JOURNAL OF ELECTROCARDIOLOGY, 2012, 45 (06) : 770 - 773
  • [50] QT Dispersion and Drug-Induced Torsade de Pointes
    Friedman, Ari
    Miles, Jeremy
    Liebelt, Jared
    Christia, Panagiota
    Engstrom, Krysthel
    Thachil, Rosy
    Grushko, Michael
    Faillace, Robert T.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (01)